STXS
Stereotaxis Inc
NYSE MKT: STXS · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$1.87
+2.75% today
Updated 2026-04-30
Market cap
$188.13M
P/E ratio
—
P/S ratio
5.81x
EPS (TTM)
$-0.25
Dividend yield
—
52W range
$2 – $4
Volume
0.4M
Stereotaxis Inc (STXS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-66.80%
Operating margin
-61.20%
ROE
-143.60%
ROA
-25.20%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $27.19M | $-45.72M | 52.59% | -171.64% | -168.14% |
| 2007 | $39.30M | $-48.12M | 60.95% | -125.30% | -122.45% |
| 2008 | $40.37M | $-43.89M | 64.88% | -101.62% | -108.72% |
| 2009 | $51.15M | $-27.49M | 66.72% | -46.60% | -53.75% |
| 2010 | $54.05M | $-19.92M | 71.20% | -35.08% | -36.86% |
| 2011 | $41.99M | $-32.03M | 70.23% | -76.07% | -76.29% |
| 2012 | $46.56M | $-9.24M | 68.26% | -22.82% | -19.84% |
| 2013 | $38.03M | $-68.76M | 71.07% | -23.25% | -180.79% |
| 2014 | $35.01M | $-5.20M | 76.51% | -15.38% | -14.86% |
| 2015 | $37.67M | $-7.35M | 72.29% | -14.36% | -19.52% |
| 2016 | $32.16M | $-5.29M | 76.59% | -19.98% | -16.44% |
| 2017 | $31.14M | $-5.89M | 65.47% | -19.01% | -18.90% |
| 2018 | $29.35M | $116756.00 | 80.52% | -8.37% | 0.40% |
| 2019 | $28.90M | $-4.23M | 78.77% | -16.70% | -14.65% |
| 2020 | $26.63M | $-6.45M | 71.22% | -25.21% | -24.23% |
| 2021 | $35.02M | $-10.72M | 66.34% | -36.80% | -30.60% |
| 2022 | $28.15M | $-19.15M | 65.62% | -66.71% | -68.04% |
| 2023 | $26.77M | $-20.71M | 55.51% | -81.58% | -77.37% |
| 2024 | $26.92M | $-24.05M | 54.22% | -91.91% | -89.33% |
| 2025 | $32.38M | $-21.64M | 52.73% | -68.30% | -66.85% |